Related Experiment Video
Updated: May 24, 2025

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
375
Reply to: "STRIDE's efficacy and safety in Asian hepatocellular carcinoma"
George Lau1, Ghassan K Abou-Alfa2, Stephen L Chan3
1Humanity and Health Clinical Trial Center, Humanity and Health Medical Group, Hong Kong Special Administrative Region of China.
Journal of Hepatology
|March 2, 2025
Abstract
No abstract available in PubMed .

